🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of Combined Oral Contraceptive Pills on Migraine

RecruitingPhase 4Ages 18 Years - 55 YearsFemaleKafrelsheikh University
NCT06509503 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The investigators will assess the effect of combined oral contraceptive pills (COCs) on migraine features and treatment response to allow better interpretation of the exact consequence of hormonal contraceptive use on migraineurs.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * female migraine patients on COCs or mechanical contraceptive methods, according to the International Classification of Headache Disorders 3rd edition, aged 18-55 years Exclusion Criteria: 1. Patients with major neurological conditions such as (epilepsy, ischemic or hemorrhagic stroke, multiple sclerosis, mitochondrial diseases, and brain tumors). 2. pregnant, lactating, and menopausal patients. 3. Patients with any contraindications to ibuprofen or propranolol.
💊

What it tests

  • Combined oral contraceptive
  • Vaginal Ring
📍

Where

1 site
Kafr Elsheikh University Hospital
Kafr ash Shaykh, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy